kaempferol analog (methicillin-resistant staphylococcus aureus infection)

N/A

Report date: 2025/01/26 18:12:52
NME

Base Information

Drug Namekaempferol analog (methicillin-resistant staphylococcus aureus infection)
Drug Alias Nameanti-MRSA KCR (methicillin-resistant staphylococcus aureus infection)kaempferol 3-O-alpha-L-(2",3"-di-p-coumaroyl)rhamnoside
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies21st Century Therapeutics Inc
China Registration ClassN/A

Develop Information

Active Companies21st Century Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A